As the UAE strengthens its efforts to combat diabetes, healthcare professionals emphasize the importance of early detection, lifestyle changes, and mental health support. With World Diabetes Day highlighting the theme of 'Early Action on Diabetes,' experts stress that timely dia…
The shift from injectable GLP-1 medications to oral pills presents a significant opportunity to improve diabetes and obesity treatment accessibility, particularly in the Global So…
Eli Lilly's experimental obesity treatment, combining eloralintide and Mounjaro, has demonstrated an average weight loss of 23% in individuals with diabetes, highlighting its pote…
New research indicates that for some individuals with diabetes, experiencing fluctuations in blood sugar levels may be linked to a better quality of life, challenging the notion t…
Dozens of lawsuits have been filed against the manufacturers of GLP-1 drugs like Ozempic and Wegovy, alleging that users were not adequately warned about the risk of a rare type o…
A recent study investigates the effects of GLP-1 medications, such as Ozempic, on physical and mental health, employment, and relationships among adults with diabetes. While these…
The FDA has granted approval for Mounjaro (tirzepatide) to reduce cardiovascular risk in individuals with type 2 diabetes, marking a significant development in diabetes management…
GLP-1 medications, known for their role in treating diabetes and obesity, are being studied for additional health benefits, including improvements in heart health and potential ca…
GLP-1 receptor agonists, initially developed for diabetes treatment, are being studied for their effects on weight loss and metabolic health in older adults. Recent research sugge…
Researchers at UC Berkeley have discovered that the compound TOFA can enhance energy expenditure and reduce body fat without causing muscle loss in mice. This approach contrasts w…
As obesity medications evolve, researchers are exploring new hormone combinations to enhance treatment effectiveness and tolerability. Current studies focus on therapies that not…
Researchers from East China Normal University have developed a probiotic that can sense and respond to glucose levels, potentially transforming type 2 diabetes treatment. This inn…